Related Experiment Video
Updated: Jun 8, 2026
06:08
Evaluation of Drug Sorption to PVC- and Non-PVC-based Tubes in Administration Sets Using a Pump
Published on: March 11, 2017
Drug-related problems at discharge: results on the Spanish pharmacy discharge programme CONSULTENOS
Maángeles Pardo López1, Ma Teresa Aznar Saliente, Enrique Soler Company
1Pharmacy Department, Hospital Universitario de San Juan, Alicante, Spain.
The International Journal of Pharmacy Practice
|September 16, 2010
Summary
Drug-related problems (DRPs) are common after hospital discharge. A pharmaceutical care program effectively identified and resolved these issues, improving patient outcomes in 80% of cases.
Area of Science:
- Pharmaceutical Care
- Patient Safety
- Health Outcomes
Background:
- Drug-related problems (DRPs) frequently arise post-discharge, impacting patient safety and treatment efficacy.
- The CONSULTENOS program aimed to mitigate these issues through structured pharmaceutical interventions.
Purpose of the Study:
- To identify common DRPs after hospital discharge.
- To document pharmacist interventions and their outcomes within the CONSULTENOS program.
- To evaluate the effectiveness of a pharmaceutical care program in managing post-discharge DRPs.
Main Methods:
- An observational, prospective, multicenter study involving 7711 patients from 10 hospitals.
- DRPs were identified using the Iaser methodology and classified at discharge and 7 days post-discharge.
- Pharmacist interventions and patient outcomes were prospectively recorded.
Main Results:
- DRPs were detected in 23.7% of patients, with 'need for additional treatment' and 'unnecessary treatment' being most common at discharge.
- Adverse effects were the most frequent DRPs identified during follow-up.
- Pharmacist interventions were accepted in 85% of cases, leading to positive outcomes in 80% of patients.
Conclusions:
- DRPs are a significant issue following hospital discharge.
- Pharmaceutical care programs are effective in identifying and resolving post-discharge DRPs.
- Further research is needed to better quantify the clinical impact of pharmacist interventions.
Related Concept Videos
01:19Pharmacovigilance
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
01:26Pharmaceutical Poisoning: Potential Scenarios
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
01:31Discharge Summary Forms
The discharge summary is crucial as it enables a smooth transition from a healthcare facility to a patient's home or another care setting. This critical document facilitates seamless continuity of care, ensuring patients receive the necessary support and attention.
Here's a detailed look at the key components and guidelines for preparing a discharge summary:
Here's a detailed look at the key components and guidelines for preparing a discharge summary:
01:24Drug Toxicity: Risk factors
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
01:08Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
01:28Dosage Regimens: Designs and Approaches
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...